Teva asks US judge not to disclose its Israeli origins to jurors
Teva Pharmaceutical Industries asked a U.S. judge to prevent the company that filed a lawsuit against it from telling a random selection of jurors that it is Israeli-based, Reuters reported on Thursday.
Teva is one of several drug makers facing a lawsuit filed by health insurance company Humana over allegations of price-fixing. The case, Humana Inc. v. Actavis Elizabeth, LLC, et al., is scheduled to go to trial on Sept. 15 in the U.S. District Court for the Eastern District of Pennsylvania in Philadelphia.
In a filing submitted on Wednesday to a federal court in Philadelphia, Teva stated, “In the period of almost three years since the start of the Gaza War, anything connected with Israel has been subject to the highest levels of controversy, with emotions running high,” Reuters reported.
The firm added that its Israeli origins are irrelevant to the case and that “references to a foreign parent company are potentially prejudicial.”
It cited a recent opinion survey that said it found 60% of Americans have a negative view of Israel. Teva also pointed to U.S. college campus protests over Israel and violent acts against individuals and institutions thought to have links to the Jewish state.
Teva denies that it had conspired with other pharmaceuticals to keep prices of drugs artificially high.
Since the war in Gaza started in the wake of the Hamas-led invasion on Oct. 7, 2023, polls have found that public opinion in the United States and other Western countries regarding Israel has become more negative, especially within the younger generation.
Get the latest updates in our WhatsApp group.
Test yourself on one question pulled from JNS reporting. New puzzles daily.
Teva Pharmaceutical Industries, an Israeli-based drug manufacturer, has requested a U.S. judge to prevent the disclosure of its Israeli origins to jurors in an upcoming antitrust lawsuit. The company, along with several other pharmaceutical firms, is being sued by health insurance company Humana over allegations of price-fixing. Teva argued in a federal court filing in Philadelphia that its Israeli origins are irrelevant and potentially prejudicial, citing the high level of controversy surrounding Israel since the Gaza War began and a recent survey indicating 60% of Americans hold a negative view of Israel. The trial, Humana Inc. v. Actavis Elizabeth, LLC, et al., is scheduled to commence on September 15 in the U.S. District Court for the Eastern District of Pennsylvania. Teva denies conspiring to artificially inflate drug prices.
© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.
Discussion
No comments yet — be the first to comment.